Research and Markets: Emerging Drug Formulation Technologies: Challenges and Opportunities

AddThis Social Bookmark Button

DUBLIN-(Business Wire)-September 14, 2009 - Research and Markets (http://www.researchandmarkets.com/research/4715ef/emerging_drug_form) has announced the addition of the "Emerging Drug Formulation Technologies: Challenges and Opportunities" report to their offering.

Advances in particle engineering, encapsulation, surface property optimization and solubility enhancement are enabling the creation of new formulations of both new and existing compounds. These technologies can enhance key properties such as compound solubility or bioavailability salvaging promising NCEs that would otherwise be dropped and modulate release profiles to achieve dosage forms that enhance patient compliance. While their potential is obvious, their use can result in complexities that can percolate throughout the organization. This impact extends beyond potential future drug therapeutics by bestowing valuable capabilities on formulators attempting to re-formulate approved drugs approaching the end of their patent life. The new generation of formulations based on proprietary technology will present challenges to downstream pharmaceutical functions.

The study presents qualitative and quantitative data and information on key market measures and benchmarks:

  • Drug Formulation Market Dynamics
  • User Segment Analysis
  • Technology Drivers
  • Alliances and Strategies
  • Formulation Economic Factors
  • Participant Profiles
  • Formulation Market Impact
  • Competitive Landscape
  • Therapeutic Demand Drivers
  • Regulatory Factors
  • Commercial Risk Factors
  • Forecasts & Projections to 2011

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations. Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.

Feature Summary:

  • Analyzes and evaluates drug formulation processes and technologies for improving the properties of insoluble, unstable, and/or poorly absorbed drug candidates
  • Examines drug formulation technology issues and evolving market factors
  • Provides detailed analysis and status of drug formulation technology platforms
  • Forecasts the impact of formulation technology on drug development and manufacturing activities
  • Profiles drug formulation technology market participants, their research activity, proprietary technology, and business strategies
  • Evaluates the impact of economic, technology, and regulatory factors on drug formulation strategies and therapies

Over 40 Companies Included in this Report, Some Include:

  • Access Pharmaceuticals
  • Acusphere
  • AdvanCell
  • AlphaRx
  • Aphios
  • Baxter
  • BioAlliance Pharma
  • Biophan Technologies
  • BioSante Pharmaceuticals
  • Camurus AB
  • Capsulution Nanoscience AG
  • Cyclolab Ltd
  • CyDex
  • Dendritic Nanotechnologies
  • Elan
  • Enzon Pharmaceuticals
  • Lipocine
  • Nanobiotix
  • NanoCarrier
  • NanoMed Pharmaceuticals
  • Nanospectra Biosciences
  • Nektar Therapeutics
  • Novavax
  • Novosom AG
  • SoluBest Technology
  • Starpharma Holdings
  • SupraTek Pharma
  • SkyePharma
  • Transgenex Therapeutics

For more information visit http://www.researchandmarkets.com/research/4715ef/emerging_drug_form

Send this news item to a friend.

Print This Page

AddThis Social Bookmark Button


Join Our Email List
Receive Updates On Features, Specials & Offers  
For Email Marketing you can trust



Search Our News Using Google Search

Can't find what you want? Try using Google:

Google